Literature DB >> 2065071

Specific binding of glycyrrhetinic acid to the rat liver membrane.

M Negishi1, A Irie, N Nagata, A Ichikawa.   

Abstract

Glycyrrhetinic acid bound specifically to a particulate fraction of rat liver. The binding was dependent on time, temperature and pH, equilibrium being reached after 10 min at 37 degrees C. The equilibrium dissociation constant and the maximal concentration of the binding site, as determined by Scatchard plot analysis, were 31 nM and 43 pmol/mg protein, respectively, indicating a single binding site entity. The binding site was highly specific for glycyrrhetinic acid, glycyrrhizin, various steroids, various fatty acids and retinoids showing no or only very low affinity. The binding was inhibited by boiling or treatment with trypsin or phospholipases. The specific activity of glycyrrhetinic acid binding was the highest in the liver, followed by in the kidney. The results suggest that glycyrrhetinic acid plays a significant role in the rat liver through its specific binding protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065071     DOI: 10.1016/0005-2736(91)90253-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  30 in total

Review 1.  Polymeric Nanostructures for Imaging and Therapy.

Authors:  Mahmoud Elsabahy; Gyu Seong Heo; Soon-Mi Lim; Guorong Sun; Karen L Wooley
Journal:  Chem Rev       Date:  2015-08-04       Impact factor: 60.622

2.  In vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin.

Authors:  Xiu-Hua Wang; Qin Tian; Wei Wang; Chuang-Nian Zhang; Ping Wang; Zhi Yuan
Journal:  J Mater Sci Mater Med       Date:  2012-04-27       Impact factor: 3.896

3.  Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.

Authors:  Jinming Zhang; Min Zhang; Juan Ji; Xiefan Fang; Xin Pan; Yitao Wang; Chuanbin Wu; Meiwan Chen
Journal:  Pharm Res       Date:  2015-07-07       Impact factor: 4.200

4.  Design and synthesis of dual-ligand modified chitosan as a liver targeting vector.

Authors:  Houxiang Chen; Min Li; Tao Wan; Qichang Zheng; Mingrong Cheng; Shiqi Huang; Yong Wang
Journal:  J Mater Sci Mater Med       Date:  2011-11-22       Impact factor: 3.896

5.  Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier.

Authors:  Wei Huang; Wei Wang; Ping Wang; Chuang-Nian Zhang; Qin Tian; Yue Zhang; Xiu-Hua Wang; Rui-Tao Cha; Chun-Hong Wang; Zhi Yuan
Journal:  J Mater Sci Mater Med       Date:  2011-03-04       Impact factor: 3.896

Review 6.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

7.  Inhibiting hepatic gluconeogenesis by chitosan lactate nanoparticles containing CRTC2 siRNA targeted by poly(ethylene glycol)-glycyrrhetinic acid.

Authors:  Ali Rastegari; Fatemeh Mottaghitalab; Rassoul Dinarvand; Mohsen Amini; Ehsan Arefian; Mahdi Gholami; Fatemeh Atyabi
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

8.  Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes.

Authors:  Sheng-Jun Mao; Shi-Xiang Hou; Ru He; Liang-Ke Zhang; Da-Peng Wei; Yue-Qi Bi; Hui Jin
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

9.  Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery.

Authors:  Amr Hefnawy; Islam H Khalil; Kholoud Arafa; Marwan Emara; Ibrahim M El-Sherbiny
Journal:  Int J Nanomedicine       Date:  2020-02-05

10.  A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation.

Authors:  Jingde Chen; Hong Jiang; Yin Wu; Yandong Li; Yong Gao
Journal:  Drug Des Devel Ther       Date:  2015-04-20       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.